AZD0171
astrazeneca
['solid tumor']
phase i, #first-in-human study of msc-1 (azd0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors #esmo22 
The #OpenAccess journal of @myESMO dedicated to #oncology research